Skip to main content
Equibles
LITS logo

LITS · Lite Strategy, Inc. · Metrics

Track LITS — free

Use LITS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LITS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.91 -0.08 (-7.94%) At close · Nov 12
Rebalance outlook locked
Market Cap
$27.10M
Shares
29.88M
Volume · Nov 12 258.2K Avg daily vol (3M) 507.77K

LITS metrics

79 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.91
Market cap
$27.10M

Price action

23 metrics
Price change (1W)
-8.8%
Price change (30D)
-18.6%
Price change (3M)
+7.1%
Price change (6M)
-16.5%
Price change (YTD)
-25.4%
Price change (1Y)
-52.6%
Trailing year
Price change (5Y)
—
52-week high
$2.08
52-week low
$0.74
Change from 52-week high
-52.6%
Change from 52-week low
+33.1%
Annualized volatility
77.9%
Annualized volatility (3M)
89.3%
Implied volatility (30D)
245.9%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.2
RSI (14D)
41.4
Price vs SMA 50
-16.0%
Price vs SMA 200
-8.7%
Avg volume (3M)
504,268
Relative volume
0.2
Average dollar volume
$619,085

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
29.88M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.5
reciprocal yield 192.6%
FCF yield
—
TTM · current market cap
Buyback yield
24.8%
P / FCF
—
P / operating cash flow
—
Earnings yield
-174.9%

Historical valuation

8 metrics
P / E historical average (3Y)
1.2×
reciprocal yield 85.8%
P / E historical average (5Y)
1.2×
reciprocal yield 85.8%
EV / revenue historical average (3Y)
-0.7×
EV / revenue historical average (5Y)
-0.7×
EV / EBIT historical average (3Y)
-1.4×
EV / EBIT historical average (5Y)
-1.4×
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
24.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2023-11-16

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2023-09-26

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
$34.75M
Operating profit (TTM)
−$48.32M
Net income (TTM)
−$51.49M
Trailing 12 months
Diluted EPS (TTM)
$-1.46
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
$5.86
Operating profit per diluted share (TTM)
$-1.28
EBITDA per diluted share (TTM)
$-1.85
Net income per diluted share (TTM)
$-1.37
Operating cash flow per diluted share (TTM)
$-0.19
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.00
Stock compensation per diluted share (TTM)
$0.03
Book value per share
$1.28

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+12.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-90.8%
Return on assets
-88.2%
Debt / equity
0.0
Current ratio
3.6
EBITDA (TTM)
−$66.58M
Free cash flow (TTM)
—
Quick ratio
3.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$4.28M
Latest balance sheet
Cash & equivalents
$4.28M
Total assets
$58.40M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.79M
Capital expenditures (TTM)
—
R&D (TTM)
$134,000
SG&A (TTM)
—
Stock compensation (TTM)
$1.12M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
35
13F filer change QoQ
-1
Institutional ownership
22.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
8.3%
Private-fund adviser ownership
7.4%
Active holders' share change QoQ
-1.6%
Holder tenure
6.3
Price vs estimated holder cost
-57.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.9%

Short interest

3 metrics
Short interest
0.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1262104 CUSIP 55279B301 13F (30d) 21 filings 19 filers Visit website Investor relations